[{"address1": "500 West 5th Street", "address2": "Suite 1200", "city": "Austin", "state": "TX", "zip": "78701", "country": "United States", "phone": "512 900 4690", "website": "https://www.shattucklabs.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. The company was incorporated in 2016 and is headquartered in Austin, Texas.", "fullTimeEmployees": 105, "companyOfficers": [{"maxAge": 1, "name": "Dr. Taylor H. Schreiber M.D., Ph.D.", "age": 43, "title": "Co-Founder, CEO & Director", "yearBorn": 1980, "fiscalYear": 2022, "totalPay": 783745, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Abhinav A. Shukla Ph.D.", "age": 50, "title": "Chief Technical Officer", "yearBorn": 1973, "fiscalYear": 2022, "totalPay": 567398, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Arundathy Nirmalini Pandite M.B.A., M.D.", "age": 64, "title": "Chief Medical Officer", "yearBorn": 1959, "fiscalYear": 2022, "totalPay": 678764, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew R. Neill M.B.A.", "age": 37, "title": "Chief Financial Officer", "yearBorn": 1986, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Conor  Richardson CPA", "title": "Vice President of Investor Relations", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen  Stout J.D., Ph.D.", "title": "General Counsel, Corporate Secretary and Chief Ethics & Compliance Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Casi  DeYoung", "age": 52, "title": "Chief Business Officer", "yearBorn": 1971, "fiscalYear": 2022, "totalPay": 523482, "exercisedValue": 0, "unexercisedValue": 493071}, {"maxAge": 1, "name": "Dr. Thomas  Lampkin Pharm.D.", "title": "Senior Vice President of Regulatory Affairs", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. George  Fromm Ph.D.", "title": "Chief Scientific Officer of ARC Platform", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Suresh de Silva Ph.D.", "title": "Chief Scientific Officer of GADLEN Platform", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 3, "boardRisk": 6, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 6, "governanceEpochDate": 1704067200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 9.41, "open": 9.31, "dayLow": 8.4437, "dayHigh": 9.67, "regularMarketPreviousClose": 9.41, "regularMarketOpen": 9.31, "regularMarketDayLow": 8.4437, "regularMarketDayHigh": 9.67, "beta": 2.204, "forwardPE": -4.4296875, "volume": 676530, "regularMarketVolume": 676530, "averageVolume": 1675410, "averageVolume10days": 622770, "averageDailyVolume10Day": 622770, "bidSize": 800, "askSize": 1000, "marketCap": 361339168, "fiftyTwoWeekLow": 1.33, "fiftyTwoWeekHigh": 10.66, "priceToSalesTrailing12Months": 271.07214, "fiftyDayAverage": 4.35834, "twoHundredDayAverage": 2.91921, "currency": "USD", "enterpriseValue": 264651056, "floatShares": 29306912, "sharesOutstanding": 42485500, "sharesShort": 1447025, "sharesShortPriorMonth": 316323, "sharesShortPreviousMonthDate": 1701302400, "dateShortInterest": 1703808000, "sharesPercentSharesOut": 0.0341, "heldPercentInsiders": 0.13019, "heldPercentInstitutions": 0.44838002, "shortRatio": 0.34, "shortPercentOfFloat": 0.0529, "impliedSharesOutstanding": 42485500, "bookValue": 2.655, "priceToBook": 3.20339, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -95022000, "trailingEps": -2.24, "forwardEps": -1.92, "enterpriseToRevenue": 198.538, "enterpriseToEbitda": -2.779, "52WeekChange": 2.6192307, "SandP52WeekChange": 0.21761274, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "STTK", "underlyingSymbol": "STTK", "shortName": "Shattuck Labs, Inc.", "longName": "Shattuck Labs, Inc.", "firstTradeDateEpochUtc": 1602250200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "64a83d67-d0cd-3885-8206-d0f94edae33a", "messageBoardId": "finmb_378179277", "gmtOffSetMilliseconds": -18000000, "currentPrice": 8.505, "targetHighPrice": 28.0, "targetLowPrice": 10.0, "targetMeanPrice": 15.5, "targetMedianPrice": 12.0, "recommendationMean": 1.7, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 101074000, "totalCashPerShare": 2.379, "ebitda": -95216000, "totalDebt": 4386000, "quickRatio": 7.189, "currentRatio": 8.037, "totalRevenue": 1333000, "debtToEquity": 3.889, "revenuePerShare": 0.031, "returnOnAssets": -0.35117, "returnOnEquity": -0.60872, "grossProfits": -82247000, "freeCashflow": -52760248, "operatingCashflow": -85650000, "revenueGrowth": 2.236, "operatingMargins": -41.688053, "financialCurrency": "USD", "trailingPegRatio": null}]